KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Elanco Animal Health (ELAN) Net Income towards Common Stockholders: 2016-2024

Historic Net Income towards Common Stockholders for Elanco Animal Health (ELAN) over the last 9 years, with Dec 2024 value amounting to $338.0 million.

  • Elanco Animal Health's Net Income towards Common Stockholders fell 109.34% to -$34.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $36.0 million, marking a year-over-year decrease of 82.44%. This contributed to the annual value of $338.0 million for FY2024, which is 127.46% up from last year.
  • Latest data reveals that Elanco Animal Health reported Net Income towards Common Stockholders of $338.0 million as of FY2024, which was up 127.46% from -$1.2 billion recorded in FY2023.
  • In the past 5 years, Elanco Animal Health's Net Income towards Common Stockholders ranged from a high of $338.0 million in FY2024 and a low of -$1.2 billion during FY2023.
  • Moreover, its 3-year median value for Net Income towards Common Stockholders was -$78.0 million (2022), whereas its average is -$323.7 million.
  • In the last 5 years, Elanco Animal Health's Net Income towards Common Stockholders slumped by 1,478.21% in 2023 and then skyrocketed by 127.46% in 2024.
  • Over the past 5 years, Elanco Animal Health's Net Income towards Common Stockholders (Yearly) stood at -$574.0 million in 2020, then rose by 15.85% to -$483.0 million in 2021, then skyrocketed by 83.85% to -$78.0 million in 2022, then slumped by 1,478.21% to -$1.2 billion in 2023, then surged by 127.46% to $338.0 million in 2024.